Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/10/1998WO1998055476A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use
12/10/1998WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
12/10/1998WO1998055474A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055469A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
12/10/1998WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998WO1998055463A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
12/10/1998WO1998055453A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998WO1998055439A1 Indane compounds and their pharmaceutical use
12/10/1998WO1998055161A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055127A1 Use of vitamin d compounds to prevent transplant rejection
12/10/1998WO1998055126A2 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
12/10/1998WO1998055125A1 Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
12/10/1998WO1998055124A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/10/1998WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055122A1 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/10/1998WO1998055121A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/10/1998WO1998055120A1 Anti-viral compounds
12/10/1998WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055118A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
12/10/1998WO1998055117A1 Method for decreasing the appetite in bulimic, overweight individuals
12/10/1998WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055115A1 Carboxamides useful as 5-ht1f agonists
12/10/1998WO1998055114A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
12/10/1998WO1998055113A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
12/10/1998WO1998055112A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998WO1998055111A1 Cembranoid inhibitors of nicotinic acetylcholine receptors
12/10/1998WO1998055110A2 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
12/10/1998WO1998055107A1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
12/10/1998WO1998055106A1 Method for preparing pharmaceutical formulation
12/10/1998WO1998055103A1 Anti-tumoral therapy agent
12/10/1998WO1998055102A1 Microcrystalline cellulose: alginate pharmaceutical suspensions
12/10/1998WO1998055091A1 Pyrrolidine derivative hair growth compositions and uses
12/10/1998WO1998055090A1 Hair growth compositions and uses
12/10/1998WO1998055085A1 Pharmaceutical compositions and methods
12/10/1998WO1998055076A2 Preparation for topical application to the male sexual organ
12/10/1998WO1998055075A2 Compositions and methods for inhibiting photoaging of skin
12/10/1998WO1998055074A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998WO1998054982A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
12/10/1998WO1998054966A1 A method of treating cancer
12/10/1998WO1998054962A1 Anti-arrhythmic composition and methods of treatment
12/10/1998WO1998054958A1 Compositions and methods for sedating, anaesthetising and euthanising aquatic organisms
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998037868A3 Nimesulide topical formulations in the form of liquid crystals
12/10/1998WO1998036728A3 Sustained analgesia achieved with buprenorphine
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/10/1998WO1998033893A3 Ribozymes cleaving epidermal growth factor receptors
12/10/1998WO1998030900A3 Screening method for compounds active in treating myopia and hypermetropia
12/10/1998WO1998030212A3 Use of aminothiazoles for treating wounds and skin
12/10/1998DE19724796A1 Mittel zur Antitumortherapie Means for antitumor therapy
12/10/1998DE19724788A1 Quadratisch-planar koordinierte Platin(II)-Komplexe, Verfahren zu ihrer Herstellung sowie ihre Verwendung Square-planar coordinated platinum (II) complexes, methods for their preparation and their use
12/10/1998DE19723722A1 Nichtsteroidale Gestagene Non-steroidal progestins
12/10/1998DE19723308A1 Microemulsions useful for topical administration of e.g. local anaesthetics
12/10/1998CA2333352A1 Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione
12/10/1998CA2294547A1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
12/10/1998CA2293595A1 Modified low molecular weight heparin that inhibits clot associated coagulation factors
12/10/1998CA2293587A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998CA2293508A1 Anti-viral compounds
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2293265A1 Anti-arrhythmic composition and methods of treatment
12/10/1998CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2292837A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998CA2292746A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use
12/10/1998CA2292734A1 Use of vitamin d compounds to prevent transplant rejection
12/10/1998CA2292699A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998CA2292698A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
12/10/1998CA2292668A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998CA2292642A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
12/10/1998CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292536A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
12/10/1998CA2292525A1 11.beta.-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments
12/10/1998CA2292478A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998CA2292471A1 A method of treating cancer
12/10/1998CA2292398A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291719A1 Microcrystalline cellulose: alginate pharmaceutical suspensions
12/10/1998CA2291647A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291624A1 Carboxamides useful as 5-ht1f agonists
12/10/1998CA2291153A1 Benzonaphthyridine
12/10/1998CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998CA2290806A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998CA2290775A1 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
12/10/1998CA2290695A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998CA2289524A1 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2288898A1 Process for preparing etoposide
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2283319A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/10/1998CA2262463A1 New uses for compounds which reduce c-jun gene expression
12/10/1998CA2262388A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998CA2260861A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
1 ... 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 6588 ... 7860